Novartis Files Suit To Stop Chinese Entresto Generic
By Elliot Weld · April 12, 2023, 5:29 PM EDT
Swiss pharmaceutical giant Novartis AG filed a patent infringement suit Monday claiming China's Nanjing Noratech Pharmaceutical Co. is attempting to manufacture and distribute a generic version of the heart medication Entresto...
To view the full article, register now.